Observational Study of Multiple Sclerosis Severity in Young Adults
An observational study was planned to enroll 300 participants aged 18 to 29 to assess the severity of Multiple Sclerosis (MS) and the age of onset. However, no results have been posted, and the study's endpoints have not been reported.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
Understanding MS severity in young adults can help inform tailored approaches for this age group, especially for those with varying onset ages. However, without results, the implications remain theoretical.
What this does not prove
The study has posted no findings, making it impossible to draw any conclusions or associations regarding MS severity or related factors from this research.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- 300 · planned enrolment
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- ages from 18 Years to 29 Years; sex All
- Size of effect
- Not reported
- Secondary endpoints
- Age of MS Onset
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Trial registrationCare in Multiple Sclerosis (MS) ↗
Supporting passages (13)
study phaseStudy type: Observational
study designStudy type: Observational
subjectsParticipants: people; ages from 18 Years to 29 Years; sex All
sample sizeEnrollment: 300 participants (estimated)
peer reviewedPublication date: unknown.
primary endpointPrimary endpoints: Severity of MS
follow upFollow-up: Baseline
limitationsNo results are posted.
populationParticipants: people; ages from 18 Years to 29 Years; sex All
secondary endpoints"studyPopulation": "* Aim 1: 2-3 focus groups, each with 8-12 participants per group., aged ≥18 years with RRMS, who self-identify as a Black, Hispanic, or poverty-impacted, and are fluent in English or Spanish.\n* Aim 2: 330 young adults (ages 18-29 years of age with MS duration of 8 years or less) of whom 165 have pediatric-onset RRMS (aged 18-25) and 165 have adult-onset (aged 19-29) RRMS.
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
sample size basisEnrollment: 300 participants (estimated)
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.